腎細胞癌の疫学的予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Related Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 12
3.3.1 Incidence 12
3.3.2 Survival Rates for RCC – 8MM 14
3.4 Forecast Methodology 15
3.4.1 Sources Used 17
3.4.2 Sources Not Used 20
3.4.3 Forecast Assumptions and Methods, RCC Diagnosed Incident Cases 21
3.4.4 Forecast Assumptions and Methods, RCC Five-Year Diagnosed Prevalent Cases 21
3.4.5 Forecast Assumptions and Methods, RCC Clinical Stages at Diagnosis 22
3.5 Epidemiological Forecast for RCC (2013-2023) 23
3.5.1 Diagnosed Incident Cases of RCC 23
3.5.2 Age-Specific Diagnosed Incident Cases of RCC 25
3.5.3 Sex-Specific Diagnosed Incident Cases of RCC 27
3.5.4 Age-Standardized Diagnosed Incidence of RCC 29
3.5.5 Diagnosed Incident Cases of RCC by Clinical Stage at Diagnosis 31
3.5.6 Five-Year Diagnosed Prevalent Cases of RCC 32
3.6 Discussion 33
3.6.1 Epidemiological Forecast Insight 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 34
4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 39
4.2.1 Epidemiologists 39
4.2.2 Reviewers 39
4.2.3 Global Director of Therapy Analysis and Epidemiology 40
4.2.4 Global Head of Healthcare 40
4.3 About GlobalData 41
4.4 About EpiCast 41
4.5 Disclaimer 42